These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14756389)

  • 1. Reproducibility of nifedipine absorption from GITS tablets: comparison of single-dose pharmacokinetics using 10, 20, 40 and 60 mg nifedipine.
    Tateishi T; Okumura K; Orii Y; Tanaka T
    Int J Clin Pharmacol Ther; 2004 Jan; 42(1):58-62. PubMed ID: 14756389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation dependent pharmacokinetics--does the dosage form matter for nifedipine?
    Toal CB
    J Cardiovasc Pharmacol; 2004 Jul; 44(1):82-6. PubMed ID: 15175561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine.
    Chung M; Reitberg DP; Gaffney M; Singleton W
    Am J Med; 1987 Dec; 83(6B):10-4. PubMed ID: 3503594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of orlistat on the bioavailability of a single dose of nifedipine extended-release tablets (Procardia XL) in healthy volunteers.
    Melia AT; Mulligan TE; Zhi J
    J Clin Pharmacol; 1996 Apr; 36(4):352-5. PubMed ID: 8728349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine gastrointestinal therapeutic system (GITS) as an alternative to slow-release for tocolysis--tolerance and pharmacokinetic profile.
    Juon AM; Kühn-Velten WN; Burkhardt T; Krähenmann F; Zimmermann R; von Mandach U
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):27-32. PubMed ID: 18394772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and safety of nifedipine GITS/candesartan fixed-dose combination in subjects with hepatic impairment
.
    Liu Y; Boettcher MF; Schmidt A; Unger S; Halabi A; Brendel E; Blode H
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):246-255. PubMed ID: 28025965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine gastrointestinal therapeutic system in stable angina pectoris. Results of a multicenter open-label crossover comparison with standard nifedipine.
    Vetrovec GW; Parker VE; Cole S; Procacci PM; Tabatznik B; Terry R
    Am J Med; 1987 Dec; 83(6B):24-9. PubMed ID: 3140660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative bioavailability study of two nifedipine tablet formulations in healthy male volunteers.
    Niopas I; Daftsios AC; Xanthakis I; Nikolaidis N
    Int J Clin Pharmacol Ther; 2000 Jun; 38(6):309-14. PubMed ID: 10890580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of nifedipine from different oral dosage forms in healthy volunteers.
    Leucuţa SE; Vida-Simiti L; Căprioară MG; Făgărăşan E; Olinic N; Manasia M; Vlaicu R
    Pharmazie; 1989 May; 44(5):336-8. PubMed ID: 2772014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of bioequivalence, safety, and tolerability of a fixed-dose combination of nifedipine GITS and candesartan compared with the corresponding loose-dose combination under fed conditions
.
    Thomas D; Liu Y; Stein H; Weimann B
    Int J Clin Pharmacol Ther; 2019 Aug; 57(8):420-428. PubMed ID: 31232274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
    Grundy JS; Foster RT
    Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of nifedipine slow-release during sustained tocolysis.
    ter Laak MA; Roos C; Touw DJ; van Hattum PR; Kwee A; Lotgering FK; Mol BW; van Pampus MG; Porath MM; Spaanderman ME; van der Post JA; Papatsonis DN; van 't Veer NE
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):84-91. PubMed ID: 25407260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of nifedipine derived from a new retard tablet formulation.
    Avgerinos A; Gorrod JW
    Eur J Drug Metab Pharmacokinet; 1990; 15(4):273-8. PubMed ID: 2088764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of bioequivalence of a new fixed-dose combination of nifedipine and candesartan with the corresponding loose combination as well as the drug-drug interaction potential between both drugs under fasting conditions.
    Brendel E; Weimann B; Dietrich H; Froede C; Thomas D
    Int J Clin Pharmacol Ther; 2013 Sep; 51(9):753-62. PubMed ID: 23849325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioavailability of four controlled-release nifedipine products.
    Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Van Dyk M; Van Schalkwyk AM
    Biopharm Drug Dispos; 1994 Aug; 15(6):493-503. PubMed ID: 7993987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.